Literature DB >> 11903535

Shared mechanisms and comorbidities in neurologic and psychiatric disorders.

S D Silberstein1.   

Abstract

Migraine may be comorbid with several other neurologic and psychiatric conditions, including mood disorders (eg, depression, anxiety, panic disorder), epilepsy, stroke, and essential tremor. Comorbidity presents physicians with opportunities and challenges for both diagnosis and treatment. All diseases must be considered, and therapeutic strategies may need to be modified to avoid potential drug interactions. Comorbidities also may provide clues to the pathophysiologies and any shared mechanisms of the two disorders. Longitudinal studies have demonstrated a bidirectional influence between migraine and major depression, but not between migraine and other severe headache. Migraine is strongly and consistently associated with panic disorder. The risk of migraine in epilepsy is increased particularly in individuals with head trauma, partial seizures, and a positive family history of migraine. The influence is bidirectional. There is also growing evidence of an association between migraine and stroke, particularly among women of childbearing age and individuals who experience migraine with aura. Lastly, a bidirectional association between migraine and essential tremor also exists. These findings suggest that migraine, major depression, epilepsy, and essential tremor share one or more common etiologies. Clinicians should be mindful of them as they design treatment strategies, and also should consider the use of a single pharmacologic agent that is effective for all conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11903535     DOI: 10.1046/j.1526-4610.2001.01154-3.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  10 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 2.  Migraine and movement disorders.

Authors:  F d'Onofrio; P Barbanti; V Petretta; G Casucci; A Mazzeo; B Lecce; C Mundi; D Cologno
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 3.  Secondary headaches.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 4.  Cosensitization of pain and psychiatric comorbidity in chronic daily headache.

Authors:  Roger Cady; Kathleen Farmer; J Kent Dexter; Curtis Schreiber
Journal:  Curr Pain Headache Rep       Date:  2005-02

5.  Psychiatric comorbidity in patients with epilepsy: a population-based study.

Authors:  Mohamad Karouni; Subaneesan Arulthas; Pål G Larsson; Elisif Rytter; Svein I Johannessen; Cecilie Johannessen Landmark
Journal:  Eur J Clin Pharmacol       Date:  2010-07-29       Impact factor: 2.953

6.  Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals.

Authors:  Nicole Rosendale; Elan L Guterman; Juno Obedin-Maliver; Annesa Flentje; Matthew R Capriotti; Micah E Lubensky; Mitchell R Lunn
Journal:  Neurology       Date:  2022-07-11       Impact factor: 11.800

Review 7.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Symptom management and quality of life in glioma patients.

Authors:  Florien W Boele; Martin Klein; Jaap C Reijneveld; Irma M Verdonck-de Leeuw; Jan J Heimans
Journal:  CNS Oncol       Date:  2014-01

9.  The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura.

Authors:  Rod A Lea; Micky Ovcaric; James Sundholm; John MacMillan; Lyn R Griffiths
Journal:  BMC Med       Date:  2004-02-12       Impact factor: 8.775

10.  Self-reported insomnia as a marker for anxiety and depression among migraineurs: a population-based cross-sectional study.

Authors:  Kyung Min Kim; Dong Hyun Lee; Eun Ju Lee; Yun Ho Roh; Won-Joo Kim; Soo-Jin Cho; Kwang Ik Yang; Chang-Ho Yun; Min Kyung Chu
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.